Interpretation of the World Health Organization guideline on glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults

Precision Medication · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles